mRNAがんワクチンおよび治療の世界市場レポート 2024年

mRNAがんワクチンおよび治療の市場規模は、今後数年で急成長が見込まれます。2028年には年間平均成長率（CAGR）16.5％で1,134億1,000万米ドルに成長します。予測期間において成長が見込まれるのは、臨床試験で有望な結果が得られたこと、がん治療におけるmRNA技術の認知度と受容度が高まっていること、アンメット・メディカル・ニーズが大きいこと、患者の転帰が改善される可能性があること、治療薬が既製品で入手可能になる見込みであることなどが挙げられます。この期間に予想される主な動向には、新たな治療領域への拡大、個々の患者プロファイルに合わせた個別化医療アプローチの活用、効果と安全性を最適化するmRNA送達システムの進歩、複数の抗原を標的とする多価mRNAワクチンの開発、治療効果を高めるためのmRNA設計の最適化における人工知能と機械学習の統合などがあります。

がんの有病率の増加は、今後数年間におけるmRNAがんワクチン・治療市場の成長の原動力となります。がんは、健康な組織への異常な細胞増殖と浸潤を特徴とする多様な疾患群を包含し、座りがちな生活習慣、食生活の乱れ、環境毒素への曝露などの要因に影響されます。mRNAがんワクチンおよび治療は、がん細胞を識別して闘う免疫系の能力を高め、治療効果と患者の転帰を改善する個別化された標的療法を提供することで、がん治療において重要な役割を果たしています。例えば、米国がん協会が2023年1月に発表したデータでは、米国における新規がん症例の推定増加数が報告されており、2022年の約1,918,030症例から2023年には1,958,310症例に増加しています。乳がんは依然として重要な関心事であり、報告された症例数は2022年の287,850例から2023年には297,790例に増加します。このことは、mRNAがんワクチンおよび治療市場の成長の原動力となっていることを裏付けています。

mRNAがんワクチンおよび治療市場の主要企業は、有効性を高め、効果的ながん治療に対する需要の高まりに対応することを目的とした革新的な治療法、特にmRNAがんワクチンの開発に注力しています。mRNAがんワクチンは、メッセンジャーRNAを利用して細胞に特定の抗原を産生するよう指示し、免疫系を刺激してがん細胞を認識・標的化します。例えば、2024年5月、中国のバイオテクノロジー企業であるWestGene Biopharmaは、mRNA治療用がんワクチンであるWGc-043の治験薬申請をFDAに承認されました。この開発は、多発性硬化症やループスなどの自己免疫疾患とともに、上咽頭がん、NK T細胞リンパ腫などのさまざまな悪性腫瘍に関連する、進行したEBウイルス関連がんの治療における重要な進歩を意味します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のmRNAがんワクチンおよび治療市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のmRNAがんワクチンおよび治療市場の実績：規模と成長, 2018-2023
• 世界のmRNAがんワクチンおよび治療市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界のmRNAがんワクチンおよび治療市場：タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 腺がん
• 粘液がん
• 腺扁平上皮がん
• 世界のmRNAがんワクチンおよび治療市場：用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 感染症
• がん
• その他の用途
• 世界のmRNAがんワクチンおよび治療市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院と診療所
• 外来手術センター
• 研究機関
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界のmRNAがんワクチンおよび治療市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界のmRNAがんワクチンおよび治療市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• mRNAがんワクチンおよび治療市場：競合情勢
• mRNAがんワクチンおよび治療市場：企業プロファイル
  • Pfizer Inc.
  • Merck & Co Inc.
  • Bayer AG
  • Novartis SA
  • Sanofi AG

第31章 その他の大手企業と革新的企業

• AstraZeneca Plc
• GlaxoSmithKline Plc
• Hoffmann-La Roche AG
• Eli Lilly and Company
• Moderna Therapeutics Inc.
• BioNTech SE
• Regeneron Pharmaceuticals Inc.
• Catalent Inc.
• Sarepta Therapeutics Inc.
• Arcturus Therapeutics Holdings Inc.
• Genentech Inc.
• Immatics Biotechnologies GmbH
• CureVac N.V
• Anima Biotech
• Argos Therapeutics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

mRNA cancer vaccines and therapeutics utilize messenger RNA (mRNA) to stimulate the immune system in fighting cancer cells. This approach delivers instructions to cells to produce therapeutic proteins or enzymes, aiding in priming the immune system to identify and target cancer cells expressing specific antigens.

The main types of mRNA cancer vaccines and therapeutics include adeno carcinomas, mucinous carcinomas, and adenosquamous carcinomas. Adeno carcinomas are cancers that develop in mucus-secreting glands across the body. These treatments are applied in various fields such as infectious diseases, cancer treatment, and other medical applications. End users include hospitals and clinics, ambulatory surgical centers, research institutes, and others involved in medical research and healthcare delivery.

The mRNA market research report is one of a series of new reports from The Business Research Company that provides mRNA market statistics, including mRNA industry global market size, regional shares, competitors with a mRNA market share, detailed mRNA market segments, market trends and opportunities, and any further data you may need to thrive in the mRNA industry. This mRNA market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mRNA cancer vaccines and therapeutics market size has grown rapidly in recent years. It will grow from $52.85 billion in 2023 to $61.52 billion in 2024 at a compound annual growth rate (CAGR) of 16.4%. The growth observed in the historic period can be attributed to several factors, including changing lifestyles impacting healthcare needs, increased funding and investment support in medical research and development, favorable regulatory environments facilitating innovation, the presence of well-established healthcare infrastructures supporting treatment advancements, and the continuous development of new therapeutic pipelines.

The mRNA cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $113.41 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%. In the forecast period, growth can be attributed to promising results from clinical trials, increasing awareness and acceptance of mRNA technology in cancer treatment, significant unmet medical needs, potential for enhanced patient outcomes, and the prospect of off-the-shelf availability of treatments. Major trends anticipated in this period include expanding into new therapeutic areas, leveraging personalized medicine approaches tailored to individual patient profiles, advancements in mRNA delivery systems to optimize effectiveness and safety, development of multivalent mRNA vaccines targeting multiple antigens, and the integration of artificial intelligence and machine learning in optimizing mRNA design for enhanced therapeutic efficacy.

The increasing prevalence of cancer is set to drive growth in the mRNA cancer vaccine and therapeutic market in the coming years. Cancer encompasses a diverse group of diseases characterized by abnormal cell growth and invasion into healthy tissues, influenced by factors such as sedentary lifestyles, poor dietary habits, and exposure to environmental toxins. mRNA cancer vaccines and therapeutics play a crucial role in cancer treatment by offering personalized and targeted therapies that enhance the immune system's ability to identify and combat cancer cells, thereby improving treatment effectiveness and patient outcomes. For example, data published by the American Cancer Society in January 2023 reported an estimated increase in new cancer cases in the United States, rising from approximately 1,918,030 cases in 2022 to 1,958,310 cases in 2023. Breast cancer remains a significant concern, with reported cases increasing from 287,850 in 2022 to 297,790 in 2023. This underscores the driving force behind the growth of the mRNA cancer vaccine and therapeutics market.

Leading companies in the mRNA cancer vaccine and therapeutics market are focused on developing innovative treatments, particularly mRNA cancer vaccines, aimed at enhancing efficacy and addressing the rising demand for effective cancer therapies. mRNA cancer vaccines utilize messenger RNA to instruct cells to produce specific antigens, stimulating the immune system to recognize and target cancer cells. For instance, in May 2024, WestGene Biopharma, a China-based biotechnology company, received FDA approval for its investigational new drug application of WGc-043, an mRNA therapeutic cancer vaccine. This development represents a significant advancement in treating advanced EB virus-related cancers, associated with various malignancies such as nasopharyngeal carcinoma, NK T-cell lymphoma, and others, along with autoimmune diseases such as multiple sclerosis and lupus.

In September 2021, Sanofi Inc., a France-based pharmaceutical company, completed its acquisition of Translate Bio Inc. for $3.2 billion. This acquisition positions Sanofi to accelerate its efforts in mRNA technology, bolstering its capabilities in developing innovative vaccines and therapies. Translate Bio Inc., based in the US, specializes in mRNA therapeutics and has significantly contributed to advancing mRNA-based medicine development.

Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mRNA cancer vaccines and therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

mRNA cancer vaccines and therapeutics market consists of sales of individualized cancer treatment mRNA vaccine, infectious disease treatment mRNA vaccine, and infection prevention mRNA vaccine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

mRNA Cancer Vaccines And Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mRNA cancer vaccines and therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mRNA cancer vaccines and therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mRNA cancer vaccines and therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Adeno Carcinomas; Mucinous Carcinomas; Adenosquamous Carcinomas
• 2) By Application: Infectious Disease; Cancer; Other Applications
• 3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Research Institutes; Other End Users
• Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; Bayer AG; Novartis SA; Sanofi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. mRNA Cancer Vaccines And Therapeutics Market Characteristics

3. mRNA Cancer Vaccines And Therapeutics Market Trends And Strategies

4. mRNA Cancer Vaccines And Therapeutics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global mRNA Cancer Vaccines And Therapeutics Market Size and Growth

• 5.1. Global mRNA Cancer Vaccines And Therapeutics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global mRNA Cancer Vaccines And Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global mRNA Cancer Vaccines And Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. mRNA Cancer Vaccines And Therapeutics Market Segmentation

• 6.1. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Adeno Carcinomas
• Mucinous Carcinomas
• Adenosquamous Carcinomas
• 6.2. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Infectious Disease
• Cancer
• Other Applications
• 6.3. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Ambulatory Surgical Centers
• Research Institutes
• Other End Users

7. mRNA Cancer Vaccines And Therapeutics Market Regional And Country Analysis

• 7.1. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market

• 8.1. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China mRNA Cancer Vaccines And Therapeutics Market

• 9.1. China mRNA Cancer Vaccines And Therapeutics Market Overview
• 9.2. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India mRNA Cancer Vaccines And Therapeutics Market

• 10.1. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan mRNA Cancer Vaccines And Therapeutics Market

• 11.1. Japan mRNA Cancer Vaccines And Therapeutics Market Overview
• 11.2. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia mRNA Cancer Vaccines And Therapeutics Market

• 12.1. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia mRNA Cancer Vaccines And Therapeutics Market

• 13.1. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea mRNA Cancer Vaccines And Therapeutics Market

• 14.1. South Korea mRNA Cancer Vaccines And Therapeutics Market Overview
• 14.2. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe mRNA Cancer Vaccines And Therapeutics Market

• 15.1. Western Europe mRNA Cancer Vaccines And Therapeutics Market Overview
• 15.2. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK mRNA Cancer Vaccines And Therapeutics Market

• 16.1. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany mRNA Cancer Vaccines And Therapeutics Market

• 17.1. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France mRNA Cancer Vaccines And Therapeutics Market

• 18.1. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy mRNA Cancer Vaccines And Therapeutics Market

• 19.1. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain mRNA Cancer Vaccines And Therapeutics Market

• 20.1. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market

• 21.1. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market Overview
• 21.2. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia mRNA Cancer Vaccines And Therapeutics Market

• 22.1. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America mRNA Cancer Vaccines And Therapeutics Market

• 23.1. North America mRNA Cancer Vaccines And Therapeutics Market Overview
• 23.2. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA mRNA Cancer Vaccines And Therapeutics Market

• 24.1. USA mRNA Cancer Vaccines And Therapeutics Market Overview
• 24.2. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada mRNA Cancer Vaccines And Therapeutics Market

• 25.1. Canada mRNA Cancer Vaccines And Therapeutics Market Overview
• 25.2. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America mRNA Cancer Vaccines And Therapeutics Market

• 26.1. South America mRNA Cancer Vaccines And Therapeutics Market Overview
• 26.2. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil mRNA Cancer Vaccines And Therapeutics Market

• 27.1. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East mRNA Cancer Vaccines And Therapeutics Market

• 28.1. Middle East mRNA Cancer Vaccines And Therapeutics Market Overview
• 28.2. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa mRNA Cancer Vaccines And Therapeutics Market

• 29.1. Africa mRNA Cancer Vaccines And Therapeutics Market Overview
• 29.2. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape
• 30.2. mRNA Cancer Vaccines And Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bayer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis SA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sanofi AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. mRNA Cancer Vaccines And Therapeutics Market Other Major And Innovative Companies

• 31.1. AstraZeneca Plc
• 31.2. GlaxoSmithKline Plc
• 31.3. Hoffmann-La Roche AG
• 31.4. Eli Lilly and Company
• 31.5. Moderna Therapeutics Inc.
• 31.6. BioNTech SE
• 31.7. Regeneron Pharmaceuticals Inc.
• 31.8. Catalent Inc.
• 31.9. Sarepta Therapeutics Inc.
• 31.10. Arcturus Therapeutics Holdings Inc.
• 31.11. Genentech Inc.
• 31.12. Immatics Biotechnologies GmbH
• 31.13. CureVac N.V
• 31.14. Anima Biotech
• 31.15. Argos Therapeutics Inc.

32. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Benchmarking

33. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market

35. mRNA Cancer Vaccines And Therapeutics Market Future Outlook and Potential Analysis

• 35.1 mRNA Cancer Vaccines And Therapeutics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 mRNA Cancer Vaccines And Therapeutics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 mRNA Cancer Vaccines And Therapeutics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer